FDA reform prospects "very good" in 105th, Commerce staffer Holcombe says.
This article was originally published in The Tan Sheet
Executive Summary
FDA REFORM PROSPECTS "VERY GOOD" IN 105th CONGRESS, COMMERCE's HOLCOMBE said at the National Association of Pharmaceutical Manufacturers annual meeting on Jan. 31 in Naples, Fla. "The prospects are very good for making responsible, careful, thoughtful changes in the FD&C Act" during the 105th Congress, House Commerce Committee minority staffer Kay Holcombe said.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning